CHAPEL HILL, NC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)JAIME LEANDRO FOUNDATION FOR THERAPEUTIC CANCER VACCINES, founded in 2020, is a community nonprofit in the Diseases & Disorders sector that reported $4.8M in total revenue in fiscal year 2024. Revenue surged 91% from the prior year, signaling strong growth momentum. The organization ran a surplus of $2.4M, a strong 50% operating margin.
THE IMPROVEMENT OF ACCESS TO AND DATA ABOUT THERAPEUTIC NEOANTIGEN CANCER VACCINES.
COMPASSIONATE ACCESS VACCINE PROGRAM - PROVIDE PERSONALIZED NEOANTIGEN PEPTIDE VACCINES FOR PATIENTS WITH CANCER. DESIGN, MANUFACTURE AND DELIVER PERSONALIZED VACCINES TO THE TREATING PHYSICIAN...
COMPASSIONATE ACCESS VACCINE PROGRAM - PROVIDE PERSONALIZED NEOANTIGEN PEPTIDE VACCINES FOR PATIENTS WITH CANCER. DESIGN, MANUFACTURE AND DELIVER PERSONALIZED VACCINES TO THE TREATING PHYSICIAN THROUGH FDA COMPASSIONATE ACCESS PROTOCOL BY PARTNERING WITH EXPERTS IN ALL OF THE DESIGN, MANUFACTURE AND REGULATORY REQUIREMENTS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $4,757,844 | $2,489,623 | +0.9% |
| Expenses | $2,357,624 | $2,330,695 | +0.0% |
| Net Income | $2,400,220 | $158,928 | +14.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| WILLIAM HOOS | PRESIDENT | 8.00 |
Officer
Director
|
$30,000 | $0 | $30,000 |
| MALACHI GRIFFITH | BOARD MEMBER | 0.50 |
Director
|
$12,400 | $0 | $12,400 |
| JASON CHANG | TREASURER | 1.00 |
Director
|
$0 | $0 | $0 |
| WILLIAM GILLANDERS | BOARD MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| ANDREW JACOBS | SECRETARY | 1.00 |
Director
|
$0 | $0 | $0 |
| J MARTIN TENENBAUM | BOARD MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $4,757,844 | $2,357,624 | $2,980,237 | $2,400,220 |
| 2023 | $2,489,623 | $2,330,695 | $937,662 | $158,928 |
| 2022 | $1,344,079 | $1,279,455 | $546,360 | $64,624 |
| 2021 | $335,642 | $416,192 | $277,944 | $-80,550 |
Compare JAIME LEANDRO FOUNDATION FOR THERAPEUTIC CANCER VACCINES with other nonprofits in North Carolina and across the country.